YSIF Advanced Therapies – RNA Therapeutics: RIGImmune

Yale Startups in Formation (YSIF) is a program for entrepreneurial faculty founded and directed by the Office of Cooperative Research. Each YSIF meeting is designed to be partly educational and partly new venture seminar, aiming to serve Yale innovators and their co-founders as these teams launch their businesses.

Host:

James G. Boyle, PhD, Executive Director, Faculty Entrepreneurship & Venture Development Yale Office of Cooperative Research

Moderator:

Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director, Translational Science

Expert Panelists:

• Anna Marie Pyle, PhD, Co-Founder, RIGImmune, Inc.. Sterling Professor of Molecular, Cellular & Developmental Biology; Investigator Howard Hughes Med Inst; Prof Chemistry

• Akiko Iwasaki, PhD, Co-Founder, RIGImmune, Inc.. Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology and Professor of Epidemiology (Microbial Diseases); Professor of Molecular Cellular and Developmental Biology; Investigator, Howard Hughes Medical Institute

• Marty Driscoll, Executive Chair RIGImmune, Inc.

• Donald Corcoran, Advisor: Business Development, RIGImmune, Inc.